Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mary R Dicklin

Showing results (1-10 of 62) with videos related to

Pageof 7
Sort By:
Current Opinion in Clinical Nutrition and Metabolic Care|December 15, 2018
Strategies to improve bioavailability of omega-3 fatty acids from ethyl ester concentratesKevin C Maki, Mary R Dicklin
Journal of the American College of Cardiology|January 4, 2023
Caution Against Rejecting All Dietary Supplements for LDL Cholesterol ReductionKevin C Maki, Mary R Dicklin
Current Opinion in Lipidology|April 26, 2017
Do triglyceride-lowering drugs decrease risk of cardiovascular disease?Kevin C Maki, Mary R Dicklin
Nutrients|July 6, 2018
Omega-3 Fatty Acid Supplementation and Cardiovascular Disease Risk: Glass Half Full or Time to Nail the Coffin Shut?Kevin C Maki, Mary R Dicklin
Current Atherosclerosis Reports|March 21, 2018
Assessing Cardiovascular Disease Risk and Responses to Preventive Therapies in Clinical PracticeKevin C Maki, Mary R Dicklin
Current Opinion in Cardiology|May 16, 2020
Omega-3 fatty acid therapy for cardiovascular disease: justified or not?Kevin C Maki, Mary R Dicklin
European Heart Journal|August 8, 2022
Is there an optimal diet for primordial prevention of atherosclerosis?Kevin C Maki, Mary R Dicklin
Cardiology Clinics|May 6, 2015
Statins and diabetesKevin C Maki, Mary R Dicklin, Seth J Baum
Journal of Clinical Lipidology|September 27, 2012
Treatment options for the management of hypertriglyceridemia: strategies based on the best-available evidenceKevin C Maki, Harold E Bays, Mary R Dicklin
Endocrinology and Metabolism Clinics of North America|February 20, 2016
Statins and DiabetesKevin C Maki, Mary R Dicklin, Seth J Baum
Pageof 7

Showing results (1-10 of 62) with videos related to

Sort By:
Pageof 7
Current Opinion in Clinical Nutrition and Metabolic Care|December 15, 2018
Strategies to improve bioavailability of omega-3 fatty acids from ethyl ester concentratesKevin C Maki, Mary R Dicklin
Journal of the American College of Cardiology|January 4, 2023
Caution Against Rejecting All Dietary Supplements for LDL Cholesterol ReductionKevin C Maki, Mary R Dicklin
Current Opinion in Lipidology|April 26, 2017
Do triglyceride-lowering drugs decrease risk of cardiovascular disease?Kevin C Maki, Mary R Dicklin
Nutrients|July 6, 2018
Omega-3 Fatty Acid Supplementation and Cardiovascular Disease Risk: Glass Half Full or Time to Nail the Coffin Shut?Kevin C Maki, Mary R Dicklin
Current Atherosclerosis Reports|March 21, 2018
Assessing Cardiovascular Disease Risk and Responses to Preventive Therapies in Clinical PracticeKevin C Maki, Mary R Dicklin
Current Opinion in Cardiology|May 16, 2020
Omega-3 fatty acid therapy for cardiovascular disease: justified or not?Kevin C Maki, Mary R Dicklin
European Heart Journal|August 8, 2022
Is there an optimal diet for primordial prevention of atherosclerosis?Kevin C Maki, Mary R Dicklin
Cardiology Clinics|May 6, 2015
Statins and diabetesKevin C Maki, Mary R Dicklin, Seth J Baum
Journal of Clinical Lipidology|September 27, 2012
Treatment options for the management of hypertriglyceridemia: strategies based on the best-available evidenceKevin C Maki, Harold E Bays, Mary R Dicklin
Endocrinology and Metabolism Clinics of North America|February 20, 2016
Statins and DiabetesKevin C Maki, Mary R Dicklin, Seth J Baum
Pageof 7